Early Access — free while we kick the tires
EdgarHawk

RNXT RenovoRx, Inc. Insider Trading

Latest: CFO Bought $20K of Shares · May 2026
1 filing analyzed · Latest 2026-05-21
Insider buys
1
Insider sells
0
Unique insiders
1
Direction
Net buying
May 2026
2026-05-21
low
Mark Voll Buy
Chief Financial Officer
25,000 shares
$19,690
@ $0.79
Significance 3/10

CFO Mark Voll buys 25,000 shares of RNXT at $0.79; stock down 44.1% from 52-week high

Mark Voll, Chief Financial Officer, purchased 25,000 shares at $0.79 on 2026-05-19, increasing his holdings by 21.3% to 142,380 shares. The current price of $0.81 remains 44.1% below the 52-week high of $1.45, with the stock down 19.4% over the past 30 days and 13.9% over 90 days. His prior purchase at this ticker on 2026-03-20 returned -19.0% over 90 days, and his cross-ticker track record shows 1 prior buy with an average 90-day return of -19.0% and a 0.00% win rate. The company is unprofitable with net income of $-3.5M against quarterly revenue of $563.0K, though annual revenue growth reached 2511.6% year-over-year.

More Chemicals and Allied Products companies

Get alerts for RNXT

Add RNXT to your watchlist and we'll email you when an insider files a Form 4 — with our AI's significance score and a plain-English read of what it means.

Sign up — free during early access